– The sale of the facility eliminates $13.2M of secured debt – – Completes iBio’s transition to an AI and...
Strengthened cash position with investment by healthcare specialist investorsExpanding into cardio-metabolic...
– Leading AI and precision biologics innovators to build a diverse set of novel best-in-class obesity...
– Purchase price of $2.85 represents a premium of 148+% to last close – BRYAN, Texas and SAN DIEGO, March 26...
– Deal includes $1 million upfront and potential future milestone payments – – iBio’s proprietary therapeutic...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.